InspireMD, Inc.
NSPR
$2.47
$0.072.92%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 16.29% | -21.55% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 16.29% | -21.55% | |||
| Cost of Revenue | 18.43% | -16.42% | |||
| Gross Profit | 7.19% | -37.74% | |||
| SG&A Expenses | 23.46% | 25.23% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 13.92% | 14.78% | |||
| Operating Income | -13.60% | -22.34% | |||
| Income Before Tax | -17.78% | -22.50% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -17.78% | -21.71% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -17.78% | -21.71% | |||
| EBIT | -13.60% | -22.34% | |||
| EBITDA | -13.64% | -22.28% | |||
| EPS Basic | -15.45% | -19.03% | |||
| Normalized Basic EPS | -15.47% | -30.71% | |||
| EPS Diluted | -15.45% | -19.03% | |||
| Normalized Diluted EPS | -15.47% | -30.71% | |||
| Average Basic Shares Outstanding | 2.02% | 2.26% | |||
| Average Diluted Shares Outstanding | 2.02% | 2.26% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||